Related Experiment Video
Updated: Jul 18, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
[The main aspects of symptomatic therapy of chronic heart failure]
Diana Zaliaduonyte-Peksiene1, Lina Mikuckaite, Ausra Kavoliūniene
1Department of Cardiology, Kaunas University of Medicine, Eiveniu 2, 50009 Kaunas, Lithuania. dianazal@yahoo.com
Insights
Diuretics are essential for managing congestive heart failure, improving quality of life. Proper use and combination therapy are crucial to prevent serious complications and improve patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic heart failure management aims to enhance quality of life, prolong survival, and prevent disease progression.
- Diuretics are primary agents for symptomatic relief in congestive heart failure, offering rapid improvements.
Purpose of the Study:
- To review current guidelines for symptomatic management of congestive heart failure.
- To highlight the role and appropriate use of diuretics in heart failure treatment.
Main Methods:
- Review of European Society of Cardiology and American College of Cardiology/American Heart Association guidelines (2005).
- Analysis of diuretic use, resistance, and combination therapies in heart failure.
Main Results:
- Loop diuretics are preferred, but 10-20% of patients develop resistance, necessitating dose adjustment or combination therapy.
- Diuretics should be combined with other heart failure medications like beta-blockers and ACE inhibitors/ARBs.
- Digoxin is indicated with diuretics for heart failure with tachyarrhythmia or severe systolic dysfunction.
Conclusions:
- Diuretics are vital for symptomatic management but require careful administration to avoid adverse effects.
- Combination therapy is key for effective, long-term management of congestive heart failure.
- Adherence to guidelines ensures optimal patient care and outcomes in heart failure treatment.
Abstract:
The main aims of the treatment of chronic heart failure are to improve and to maintain the quality of life, to increase duration of life, to decrease mortality, to prevent diseases leading to the heart failure development, and to prevent the progression of heart failure. Diuretics are the drugs of first choice for the treatment of congestive heart failure. They can improve the quality of patient's life quite quickly. Noncompliance to methodological diuretic use can cause a serious damage such as metabolic disorders, arrhythmias, and even sudden death. Loop diuretics are the drugs of choice. Resistance to diuretics occurs in 10-20% of the cases during the course of treatment; therefore, drug combination as well as dose modification is required. Diuretics are not recommended to use alone for a symptomatic relief. They are prescribed in combination with beta-blockers, angiotensin-converting-enzyme inhibitors, and/or angiotensin receptor blockers for a continuous pathogenetic therapy of congestive heart failure. Digoxin in combination with diuretics is the drug of choice for treatment of heart failure when tachyarrhythmia or severe systolic left ventricular dysfunction appears or it is impossible to administer beta-blockers. In this article, the guidelines of European Society of Cardiology and also American College of Cardiology and American Heart Association for the symptomatic management of congestive heart failure, updated in 2005, are reviewed.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure